1. Adamson TC 3rd, Fox RI, Frisman DM, Howell FV. Immunohistologic analysis of lymphoid infiltrates in primary Sjögren’s syndrome using monoclonal antibodies. J Immunol 1983;130:203-8
2. Tsuboi H, et al. Primary and secondary surveys on epidemiology of Sjögren’s syndrome in Japan. Mod Rheumatol 2013;24:464-470
3. Dawson L, Tobin A, Smith P, Gordon T. Antimuscarinic antibodies in Sjögren’s syndrome. Arthritis Rheumatol 2005;52:2984-95
4. Christodoulou MI, Kapsogeorgou EK, Moutsopoulos HM. Characteristics of the minor salivary gland infiltrates in Sjögren’s syndrome. J Autoimmun. 2010;34:400-7
5. Verstappen GM, Corneth OBJ, Bootsma H, Kroese FGM. Th17 cells in primary Sjögren’s syndrome: Pathogenicity and plasticity. J Autoimmun 2018;87:16-25
6. Sakai A, Sugawara Y, Kuroishi T, Sasano T, Sugawara S. Identification of IL-18 and Th17 cells in salivary glands of patients with Sjögren’s syndrome, and amplification of IL-17- mediated secretion of inflammatory cytokines from salivary gland cells by IL-18 J Immunol 2008;181:2898-906
7. Verstappen GM, et al. Attenuation of follicular helper T cell-dependent B cell hyperactivity by abatacept treatment in primary Sjögren’s syndrome. Arthritis Rheumatol 2017;69:1850-61
8. Sumida T, Kato T, Hasunuma T, Maeda T, Nishioka K, Matsumoto I. Regulatory T cell epitope recognized by T cells from labial salivary glands of patients with Sjögren’s syndrome. Arthritis Rheumatol 1997;40:2271-3
9. Li Y, et al. A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sjögren’s syndrome at 7q11.23. Nat Genet 2013;45:1361-1365
10. Fang K., Zhang K. & Wang J. Network-assisted analysis of primary Sjögren’s syndrome GWAS data in Han Chinese. Sci Rep 2015;5:188855
11. Voigt A, Bohn K, Sukumaran S, Stewart CM, Bhattacharya I, Nguyen CQ. Unique glandular ex-vivo Th1 and Th17 receptor motifs in Sjögren’s syndrome patients using single-cell analysis. Clin Immunol 2018;192:58-67
12. Sumida T, Tsuboi H, Iizuka M, Hirota T, Asashima H, Matsumoto I. The role of M3 muscarinic acetylcholine receptor reactive T cells in Sjögren’s syndrome: A critical review. J Autoimmun 2014;51:44-50
13. Sumida T, et al. T cells and autoantigens in Sjögren’s syndrome. Mod Rheumatol 2000;10:193-8
14. Bonner TI, et al. The molecular basis of muscarinic receptor diversity. Trends Neurosci. 1989;12:148-51
15. Tsuboi H, et al. New epitopes and function of anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren’s syndrome. Clin Exp Immunol 2010;162:53-61
16. Naito Y, et al. Altered peptide ligands regulate muscarinic acetylcholine receptor reactive T cells of patients with Sjögren’s syndrome. Ann Rheum Dis 2005;65:269-71
17. Iizuka M, et al. Pathogenic role of immune response to M3 muscarinic acetylcholine receptor in Sjögren’s syndrome-like sialoadenitis. J Autoimmun. 2010;35:383-9
18. Iizuka M, et al. The crucial roles of IFN-γ in the development of M3 muscarinic acetylcholine receptor induced Sjögren’s syndrome-like sialadenitis. Mod Rheumatol 2013;23:614-6.
19. Iizuka M, et al. M3 muscarinic acetylcholine receptor reactive IL-17 producing T cells promotes development of Sjögren’s syndrome like sialadenitis. Mod Rheumatol 2015;25:158-60
20. Fujibayashi T, Sugai S, Miyasaka N, Hayashi Y, Tsubota K. Revised Japanese criteria for Sjögren’s syndrome (1999): Availability and validity. Mod Rheumatol 2004;14:425-34
21. Shiboski CH, et al. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis 2017;76:9-16.
22. Umehara H, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol 2012;22:21-30.
23. McGeachy MJ, Cua DJ, Gaffen SL. The IL-17 family of cytokines in health and disease. Immunity 2019 50:892-906
24. Ooi JD, et al. The HLA-DRB1*15:01-restricted Goodpasture’s T cell epitope induces GN. J Am Soc Nephrol. 2013:419-31
25. Dobson R, et al. A risk score for predicting multiple sclerosis. PLoS One. 2016:11(11):e0164992
26. Vogt AB, et al. Ligand motifs of HLA-DR5*0101 and DRB1*1501 molecules delineated from self-peptides. J Immunol, 1994;153:1665-73
27. Lessard CJ, et al. Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren’s syndrome. Nat Genet. 2013;45:1284-92
28. Rischmueller M, et al. HLA class II phenotype controls diversification of the autoantiody response in primary Sjögren’s syndrome (pSS). Clin Exp Immunol. 1998;111:365-71
29. Deitiker PR, et al. Subtle differences in HLA DQ haplotype-associated presentation of AChR alpha-chain peptides may suffice to mediate myasthenia gravis. Autoimmunity. 2006;39:277-88
30. Verstappen GM, et al. B cell depletion therapy normalizes circulating follicular Th cells in primary Sjögren’s syndrome. J. Rheumatol. 2017;44:49-58.
31. Lin X, et al. Th17 cells play a critical role in the development of experimental Sjögren’s syndrome. Ann Rheum Dis. 2015;74:1302-10
32. Mitsdoerffer M, et al. Proinflammatory T helper type 17 cells are effective B-cell helpers. Proc Natl Acad Sci USA. 2010;107(32):14292-7
33. Scarselli M, Li B, Kim SK, Wess J. Multiple residues in the second extracellular loop are critical for M3 muscarinic acetylcholine receptor activation. J Biol Chem 2007;282:7385- 96
34. M. Voulgarelis, et al. Pathogenic mechanisms in the initiation and perpetuation of Sjögren’s syndrome, Nat Rev Rheumatol 2010;6:529-37
35. R. Stadhouders, et al. A cellular and molecular view of T helper 17 cell plasticity in autoimmunity. J Autoimmun. 2018;87:1-15
36. Harbour S.N, et al. Th17 cells give rise to Th1 cells that are required for the pathogenesis of colitis. Proc Natl Acad Sci. U.S.A. 2015;112:7061-7066
37. Paroni M, et al. Recognition of viral and self-antigens by Th1 and Th1/Th17 central memory cells in patients with multiple sclerosis reveals distinct roles in immune surveillance and relapses. J Allergy Clin Immunol 2017;140:797-808
38. Nistala K, et al. Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment. Proc Natl Acad Sci U.S.A. 2010;107:14751-6
39. Annunziato F, et al. Phenotypic and functional features of human Th17 cells. J Exp Med. 2007;204:1849-1861
40. Wanchoo A, et al. Single-cell analysis reveals sexually dimorphic repertoires of Interferon- and IL-17A producing T cells in salivary glands of Sjögren’s syndrome mice. Sci Rep. 2017;7:12512
41. Nanke Y, et al. Detection of IFN-γ+IL-17+cells in salivary glands of patients with Sjogren’s syndrome and Mikulicz’s disease: Potential role of Th17・Th1 in pathogenesis of autoimmune diseases. Jpn J Clin Immunol, 2016;39:473-477
42. Asashima H, et al. The anergy induction of M3 muscarinic acetylcholine receptor- reactive CD4+ T cells suppresses experimental sialadenitis-like Sjögren’s syndrome. Arthritis Rheumatol. 2015;67:2213-25
43. Tahara M, et al. RORgt antagonist suppresses M3 muscarinic acetylcholine receptor- induced Sjögren’s syndrome like sialadenitis. Clin Exp Immunol. 2017;187:213-224
44. Tsuboi H, et al. Generation and functional analysis of monoclonal antibodies against the second extracellular loop of human M3 muscarinic acetylcholine receptor. Mod Rheumatol. 2012;22:264-271